{"nct_id":"NCT03814590","title":"A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults","status":"COMPLETED","status_verified_date":"2022-07","start_date":"2019-01-21","start_date_type":"ACTUAL","primary_completion_date":"2019-12-12","primary_completion_date_type":"ACTUAL","completion_date":"2020-11-30","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["GSK"]}